Related Experiment Video
Updated: Apr 12, 2026

Injectable Supramolecular Polymer-Nanoparticle Hydrogels for Cell and Drug Delivery Applications
Published on: February 7, 2021
An APS-hydrogel composite provides dual molecular-physical protection to NK-92 cells by preserving membrane stability
Yuying Wang1, Linshan Wang1, Shiwen Wang1
1School of Biomedical Engineering, Anhui Medical University, Hefei, China.
Abstract:
The surface microstructures of Natural Killer (NK) cells, such as microvilli, are essential for target cell recognition and the subsequent formation of immunological synapses. However, traditional cryopreservation protocols (e.g., 10% DMSO and serum) severely damage the cell surface structure, which further impairs cytotoxicity. Although a variety of novel cryoprotectants or ice inhibitors have emerged to improve the post-thaw viability of cells, there are currently few reports on strategies for the preservation of surface microstructures essential for immune synapse formation in natural killer (NK) cells. Here, we introduce a dual-protection strategy that combines the membrane-stabilizing capacity of Astragalus Polysaccharide (APS), a bioactive compound from traditional Chinese medicine, with a hydrogel encapsulation system to mitigate cryo-injury from ice crystal formation. The results demonstrated that, in the absence of DMSO, the experimental group achieved an 85% viability rate for NK-92 cells. Furthermore, the surface microstructure was significantly better preserved compared to conventional protocols, and the corresponding cytokine secretion and cytotoxicity showed no significant difference from the fresh group. This study demonstrates that the synergistic cryoprotective effect of APS and hydrogel, thereby laying a solid foundation for immune cell preservation and cell-based therapies.
More Related Videos
13:59High-Content Screening Assay for the Identification of Antibody-Dependent Cellular Cytotoxicity Modifying Compounds
Published on: August 18, 2023
10:49Hydrogel Arrays Enable Increased Throughput for Screening Effects of Matrix Components and Therapeutics in 3D Tumor Models
Published on: June 16, 2022